These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 17907160

  • 1. Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders.
    Cowper SE, Kuo PH, Bucala R.
    Arthritis Rheum; 2007 Oct; 56(10):3173-5. PubMed ID: 17907160
    [No Abstract] [Full Text] [Related]

  • 2. Strong association between the use of gadolinium-based contrast agents with nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Jamboti J.
    Intern Med J; 2007 Jul; 37(7):508-9; author reply 509. PubMed ID: 17547734
    [No Abstract] [Full Text] [Related]

  • 3. Evaluating the role of recombinant erythropoietin in nephrogenic systemic fibrosis.
    Goveia M, Chan BP, Patel PR.
    J Am Acad Dermatol; 2007 Oct; 57(4):725-7. PubMed ID: 17689832
    [No Abstract] [Full Text] [Related]

  • 4. Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney disease.
    Perazella MA, Rodby RA.
    Am J Med; 2007 Jul; 120(7):561-2. PubMed ID: 17602923
    [No Abstract] [Full Text] [Related]

  • 5. Nephrogenic systemic fibrosis: is any contrast safe in renal failure?
    Endre ZH.
    Intern Med J; 2007 Jul; 37(7):429-31. PubMed ID: 17547720
    [No Abstract] [Full Text] [Related]

  • 6. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Hamilton-Persaud K, Ezell LD, Macklin JG.
    Nephrol Nurs J; 2007 Jul; 34(3):283-7; quiz 288. PubMed ID: 17644872
    [Abstract] [Full Text] [Related]

  • 7. Clinical and histological findings in nephrogenic systemic fibrosis.
    Cowper SE, Rabach M, Girardi M.
    Eur J Radiol; 2008 May; 66(2):191-9. PubMed ID: 18325705
    [Abstract] [Full Text] [Related]

  • 8. Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury.
    Kalb RE, Helm TN, Sperry H, Thakral C, Abraham JL, Kanal E.
    Br J Dermatol; 2008 Mar; 158(3):607-10. PubMed ID: 18076707
    [Abstract] [Full Text] [Related]

  • 9. Nephrogenic systemic fibrosis: an overview.
    Cowper SE.
    J Am Coll Radiol; 2008 Jan; 5(1):23-8. PubMed ID: 18180005
    [Abstract] [Full Text] [Related]

  • 10. Gadolinium chelate-associated nephrogenic systemic fibrosis.
    Kei PL, Chan LP.
    Singapore Med J; 2008 Mar; 49(3):181-5. PubMed ID: 18362996
    [No Abstract] [Full Text] [Related]

  • 11. Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure.
    Othersen JB, Maize JC, Woolson RF, Budisavljevic MN.
    Nephrol Dial Transplant; 2007 Nov; 22(11):3179-85. PubMed ID: 17890246
    [Abstract] [Full Text] [Related]

  • 12. [Nephrogenic systemic fibrosis].
    Cavallini L, Abaterusso C, Bedogna V, Pertica N, Loschiavo C, Lupo A.
    G Ital Nefrol; 2008 Nov; 25(1):14-20. PubMed ID: 18264914
    [Abstract] [Full Text] [Related]

  • 13. Safety update on the possible causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis.
    Pedersen M.
    J Magn Reson Imaging; 2007 May; 25(5):881-3. PubMed ID: 17457808
    [No Abstract] [Full Text] [Related]

  • 14. Nephrogenic systemic fibrosis: a dermatologist's perspective.
    Girardi M.
    J Am Coll Radiol; 2008 Jan; 5(1):40-4. PubMed ID: 18180008
    [Abstract] [Full Text] [Related]

  • 15. Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney and liver disease.
    Shenoy C.
    Am J Med; 2008 Jan; 121(1):e11; author reply e13. PubMed ID: 18187056
    [No Abstract] [Full Text] [Related]

  • 16. Gadolinium and nephrogenic systemic fibrosis: association or causation.
    Kurtkoti J, Snow T, Hiremagalur B.
    Nephrology (Carlton); 2008 Jun; 13(3):235-41. PubMed ID: 18221255
    [Abstract] [Full Text] [Related]

  • 17. Dermal and extra-dermal manifestations of gadolinium-triggered nephrogenic fibrosing dermopathy.
    Stöllberger C, Finsterer J.
    Nephrol Dial Transplant; 2006 Dec; 21(12):3604; author reply 3604-5. PubMed ID: 17105824
    [No Abstract] [Full Text] [Related]

  • 18. Nephrogenic systemic fibrosis: more questions and some answers.
    Morcos SK, Thomsen HS.
    Nephron Clin Pract; 2008 Dec; 110(1):c24-31; discussion c32. PubMed ID: 18688172
    [Abstract] [Full Text] [Related]

  • 19. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
    Broome DR.
    Eur J Radiol; 2008 May; 66(2):230-4. PubMed ID: 18372138
    [Abstract] [Full Text] [Related]

  • 20. Gadolinium deposition in nephrogenic fibrosing dermopathy.
    Boyd AS, Zic JA, Abraham JL.
    J Am Acad Dermatol; 2007 Jan; 56(1):27-30. PubMed ID: 17109993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.